The global clinical laboratory services market was valued at USD 161.70 Billion in 2024, driven by the increasing demand for fast and accurate clinical laboratory services across the globe. The market is anticipated to grow at a CAGR of 5.20% during the forecast period of 2025-2034 to achieve a value of USD 268.45 Billion by 2034.
Base Year
Historical Year
Forecast Year
The market is expected to grow steadily due to increasing demand for early disease diagnosis and rising prevalence of chronic and infectious conditions worldwide.
Technological advancements in diagnostic techniques, including automation and molecular testing, are significantly boosting the efficiency and accuracy of laboratory services, thereby driving market expansion.
Growing investments in healthcare infrastructure and the rise of personalized medicine are fostering the demand for specialized clinical laboratory tests, supporting market growth in both developed and emerging regions.
Value in USD Billion
2025-2034
Clinical Laboratory Services Market Outlook
*this image is indicative*
Clinical laboratory services refer to diagnostic testing and analysis conducted on clinical specimens, such as blood, urine, or tissue, to provide information essential for disease prevention, diagnosis, and treatment. These services support healthcare professionals in making informed medical decisions and monitoring patient health. They encompass a wide range of disciplines, including hematology, microbiology, clinical chemistry, immunology, and molecular biology. Clinical laboratories play a crucial role in detecting infections, monitoring chronic conditions, and managing therapeutic interventions, thereby contributing significantly to improving patient outcomes and enhancing the overall efficiency of healthcare systems.
Workflow Digitization to Enhance Market Value in the Forecast Period
The increasing demand for digital transformation, coupled with the growing need for efficiency in clinical trials, is driving the adoption of automated laboratory solutions. For instance, in March 2025, IQVIA Laboratories introduced the Site Lab Navigator, an advanced suite of tools aimed at digitising and streamlining lab workflows for trial sponsors and investigator sites. Central to this solution is an innovative e-Requisition system that replaces manual paperwork with electronic processes, reducing administrative burden, human error, and improving compliance. This advancement is poised to accelerate market development by enhancing operational efficiency, enabling quicker trial execution, and fostering higher-quality data generation in clinical laboratory services.
Investments in Companion Diagnostics to Boost Clinical Laboratory Services Market Demand
Rising investments in precision medicine and the need for regulatory-compliant laboratory services are reinforcing the value of companion diagnostics in clinical research. For instance, in September 2024, Agilent Technologies launched the Biopharma CDx Services Lab (BCSL) in California after securing CLIA registration, enabling it to meet stringent standards for human specimen testing. The lab offers end-to-end support from early clinical phases to FDA approvals, integrating advanced biomarker assessment technologies. This development is expected to fuel market growth by enhancing reliability, operational efficiency, and trust in laboratory outputs, thereby attracting more biopharma clients and strengthening the market presence of high-quality, regulatory-aligned service providers.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Clinical Laboratory Services Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Test Type
Market Breakup by Provider
Market Breakup by Application
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Clinical Chemistry Testing to Lead the Segmentation by Test Type
Clinical chemistry testing is projected to hold the largest market share due to its broad applicability across routine health assessments and chronic disease monitoring. Increasing incidences of diabetes, cardiovascular disorders, and hormonal imbalances drive demand for routine and specialised chemistry testing. Innovations in biomarker identification and point-of-care diagnostics enhance test accuracy and speed, making them indispensable across healthcare settings. Additionally, the rising trend of personalised medicine and preventive healthcare supports further integration of chemistry panels in routine diagnostics. This segment’s versatility, affordability, and adaptability position it as a core driver of growth in the clinical laboratory services market during the forecast period.
Standalone Laboratories to Hold a Significant Clinical Laboratory Tests Market Share by Provider
Standalone laboratories are expected to dominate the provider segment owing to their advanced infrastructure, high testing volumes, and operational flexibility. These facilities often house specialised equipment and trained personnel, enabling them to deliver a broad spectrum of high-quality tests at faster turnaround times. With growing demand for outpatient diagnostics and decentralised healthcare, standalone labs are expanding their footprint through partnerships and digital platforms. Moreover, their cost efficiency and scalability appeal to both public and private healthcare providers. These factors collectively make standalone laboratories a pivotal growth catalyst in the clinical laboratory services market in the years ahead.
Drug Discovery and Development Services to Lead the Clinical Laboratory Tests Market Segmentation by Application
Drug discovery and development services are poised to lead the application segment, supported by increasing pharmaceutical R&D investment and a surge in novel drug pipelines. These services are critical for validating drug efficacy and safety across preclinical and clinical trial stages. Clinical laboratories offer essential bioanalytical and biomarker testing that accelerates the decision-making process in drug development. The rise of precision medicine, biologics, and gene therapies further elevates the need for sophisticated lab capabilities. As regulatory demands intensify, the reliance on laboratory partners for accurate and timely data continues to grow, positioning this segment at the forefront of market expansion.
North America is likely to hold the largest market share, primarily driven by the region's strong healthcare infrastructure, high volume of diagnostic testing, and widespread adoption of advanced laboratory technologies. The United States, in particular, benefits from a robust insurance system, significant investment in personalised medicine, and a high burden of chronic diseases that necessitate routine and specialised testing. For instance, in February 2025, CytoChip received US Food and Drug Administration 510(k) clearance and a CLIA waiver for its complete blood count testing system, enhancing point-of-care diagnostics and reinforcing the region's leadership in laboratory innovation. Europe is also seeing notable growth, especially in Germany and the UK, due to expanding molecular diagnostics and home testing services. Meanwhile, Asia-Pacific is gaining momentum with increasing healthcare access, particularly in China and India, though limited reimbursement frameworks persist. Latin America and the Middle East & Africa show moderate growth, constrained by resource availability and infrastructure limitations.
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Founded in 1967 and headquartered in Secaucus, New Jersey, Quest Diagnostics Incorporated is a leading provider of diagnostic information services. The company specialises in clinical laboratory testing, anatomic pathology, and gene-based and esoteric testing. Quest operates a vast network of laboratories and patient service centres across the United States and internationally. Its services support physicians, hospitals, insurers, and pharmaceutical companies by offering accurate test results, wellness insights, and diagnostics innovations. Quest’s extensive portfolio and ongoing investment in digital health solutions position it strongly in the evolving clinical laboratory services market.
Established in 1978 and based in Burlington, North Carolina, Labcorp is a global life sciences company providing comprehensive clinical laboratory and end-to-end drug development services. It operates one of the largest networks of central laboratories and specialises in routine and specialised testing, genomics, and clinical trials. Labcorp supports healthcare providers and pharmaceutical firms with services that span diagnostics, drug development, and companion diagnostics. Its strategic acquisitions and focus on precision medicine enhance its capabilities, ensuring its dominant role in clinical laboratory services worldwide.
Headquartered in Denver, Colorado, and established in 1999, DaVita Healthcare Partners is renowned for its kidney care and dialysis services. Through its division, DaVita Labs, the company provides high-quality clinical laboratory services tailored for renal patients. It operates a high-volume laboratory focused on delivering fast, accurate diagnostic support to nephrologists. With a strong commitment to innovation and patient-centric care, DaVita leverages technology and standardised protocols to optimise lab efficiency and outcomes, thereby strengthening its position in the clinical laboratory services market, especially within nephrology-focused diagnostics.
A subsidiary of Fresenius Medical Care, Spectra Laboratories was founded in 1982 and is headquartered in Rockleigh, New Jersey. It specialises in laboratory services for dialysis patients, offering testing in areas such as microbiology, haematology, and immunology. Spectra operates two major full-service laboratories in the U.S. and is known for its rapid turnaround, high-volume testing, and dialysis-specific diagnostic solutions. Its commitment to renal patient care and extensive logistics network make it a trusted partner for dialysis providers, positioning Spectra as a key contributor to the clinical laboratory services market’s growth.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Eurofins Scientific, Unilabs, Synlab International, Bio-Reference Laboratories, ACM Medical Laboratory, and Lifelabs Medical Laboratories.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
In 2024, the global market attained a value of approximately USD 161.70 Billion.
The global market for clinical laboratory services is projected to grow at a CAGR of 5.20% between 2025 and 2034.
The market is estimated to witness a healthy growth in the forecast period of 2025-2034, reaching a value of USD 268.45 Billion by 2034.
The major drivers of the market include the need to timely and accurately diagnose diseases, growing world population, launch of technologically advanced products, and continual research and development activities.
Ageing global population and widening scope of clinical laboratory services are the key trends propelling the market growth.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The various test types in the market for clinical laboratory services include clinical chemistry, immunology, cytology, genetics, microbiology, and haematology, among others.
The various service providers of clinical laboratory services in the market are hospital-based laboratories, stand-alone laboratories, and clinic-based laboratories.
The significant applications of clinical laboratory services include bioanalytical and lab chemistry services, toxicology testing services, cell and gene therapy related services, preclinical and clinical trial related services, and drug discovery and development related services, among others.
The major players in the market are Quest Diagnostics Incorporated, Laboratory Corporation of America® Holdings, NeoGenomics Laboratories, Abbott Laboratories, Siemens Healthcare GmbH, QIAGEN, Sonic Healthcare Limited, Eurofins Scientific, SYNLAB International GmbH, ACM Global Laboratories, ARUP Laboratories, OPKO HEALTH, INC., Mayo Medical Laboratories, DIAN DIAGNOSTICS Group Co., Ltd, Unilabs AB, and Labco Advanced Clinical Laboratory, among others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Test Type |
|
| Breakup by Provider |
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share